DRUGS related term(s) Crime

Addresses

National Health Care and Prescription Drug Policies: Robert Ingram, S11720-S11722 [20NO]

Amendments

Antitrust policy: enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs (S. 754), S11316, S11339, S11341 [18NO]

Customs Service, Office of the U.S. Trade Representative, and ITC: authorizing appropriations (H.R. 3129), H2869, H2878 [22MY]

Diseases: improve access to HIV/AIDS-related treatments and services in sub-Saharan Africa and other developing countries (H.R. 2069), S6700, S6716, S6727 [12JY]

Federal Food, Drug, and Cosmetic Act: provide greater access to affordable pharmaceuticals (S. 812), S6909, S6930, S6960, S6961, S6963 [17JY], S6978, S7048, S7049, S7050, S7060 [18JY], S7232, S7233 [23JY], S7284, S7316, S7317, S7318 [24JY], S7382 [25JY], S7435 [26JY], S7589, S7590, S7591, S7592, S7593, S7594, S7598, S7601, S7611 [30JY]

Medicare: establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (H.R. 4954), H3929 [25JN], H4226, H4297 [27JN]

Native Americans: authorize the integration and consolidation of alcohol and substance abuse programs and services provided by tribal governments (S. 210), S8696 [17SE]

Public Health Service Act: amend relative to pharmacy health professions programs (S. 1806), S9927 [3OC]

Analyses

Preservation of Antibiotics for Human Treatment Act (S. 2508), S4283 [13MY]

Research Revitalization Act (S. 3060), S9994 [4OC]

Appointments

Conferees: H.R. 3448, Public Health Security and Bioterrorism Response Act, H641 [28FE]

Parents Advisory Council on Youth Drug Abuse, S5879 [20JN]

Articles and editorials

Daschle Blames Bush Tax Cut for Failure on Prescription Drug Reform, S7423 [26JY]

Drug Prices—Why They Keep Soaring, S4273 [13MY]

Drugs, Terror and Tuna—How Goals Clash, S4562 [20MY], S4958 [4JN]

Ecstasy's Brain Drain Possibly Wider Than Thought, S9699 [1OC]

Ending Terrorism in Colombia, S6860 [16JY]

Finding a Formula for Medicare Drug Benefits, S7623 [31JY]

Jesse Helms—We Cannot Turn Away, S5151 [6JN]

Marijuana Today—Setting the Record Straight, E1545 [11SE]

Officials—Boy Swallows 87 Heroin Condoms, H1653 [25AP]

Plug the Flow of ``Incentives'', E1801 [9OC]

Unintended Consequences, E1183 [28JN]

We Filled the Prescription, E1452 [29JY]

Bills and resolutions

Animals: ensure use of certain antibiotic drugs in agriculture does not compromise human health by contributing to the development of antibiotic resistance (see S. 2508), S4281 [13MY] (see H.R. 3804), H633 [27FE]

Antitrust policy: enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs (see S. 2677), S6013 [25JN]

Central Asia: provide assistance to prevent, treat, and control HIV/AIDS, tuberculosis, malaria, polio, and other infectious diseases that affect children (see H.R. 5681), H8022 [16OC]

Children and youth: meet mental health and substance abuse treatment needs of incarcerated children and youth (see S. 1965), S1208 [26FE]

Cocaine: adjust penalties for powder cocaine and crack cocaine offenses (see H.R. 4026), H1087 [20MR]

Colleges and universities: provide grants to States to establish partnerships among colleges and universities and surrounding communities to reduce underage and binge drinking and illicit drug use by students (see S. 3167), S11079 [14NO]

Colombia: support democratically elected Government and efforts to combat narcotics trafficking and counter threats from terrorist organizations (see H.R. 4591), H1673 [25AP]

Computers: establish requirements relative to the sale of, or the offer to sell, prescription drugs through the Internet (see H.R. 4990), H3824 [21JN]

Consumers: correct impediments to allowing importation of prescription drugs into the U.S. by pharmacists and wholesalers for resale and by U.S. citizens for personal use (see H.R. 5534), H6982 [2OC]

Controlled Substances Act: amend relative to placing of certain substances on the schedules of controlled substances (see H.R. 5564), H7171 [7OC]

———treatment of salvinorin A (see H.R. 5607), H7892 [10OC]

Courts: authorize grants for establishment of quasi-judicial campus drug courts at colleges and universities (see S. 2941), S8673 [17SE]

Crime: address the problem of pseudoephedrine smuggling into the U.S. from Canada (see H. Con. Res. 317), H201 [6FE]

———foster local collaborations to ensure effective and efficient use of resources within the criminal and juvenile justice systems in dealing with mentally ill offenders (see S. 3147), S10677 [17OC] (see H.R. 5701), H8041 [24OC]

———prohibit opening, maintaining, managing, controlling, renting, leasing, making available for use, or profiting from any place for the purpose of manufacturing, distributing, or using any controlled substance (see S. 2633), S5696 [18JN] (see H.R. 5519), H6926 [1OC]

———respond to the illegal production, distribution, and use of methamphetamines (see S. 2763), S7104 [19JY] (see H.R. 3782), H523 [14FE]

Customs Service, Office of the U.S. Trade Representative, and ITC: authorizing appropriations (see H.R. 4779), H2734 [21MY]

———authorizing appropriations (H.R. 3129), consideration (see H. Res. 426), H2734 [21MY]

Dept. of HHS: establish National Vaccine Authority (see H.R. 4100), H1153 [9AP]

Dept. of Justice: implement a program which provides for dedicated commuter lanes at land points of entry into the U.S. (see H.R. 4837), H3036 [23MY]

Dept. of Veterans Affairs: establish policies for any requirement that veterans be required to split their medications as a cost-saving measures (see H.R. 4836), H3036 [23MY]

———pilot program to assess benefits of dispensing medications to veterans for prescriptions written by private practitioners (see H.R. 5332), H6059 [4SE]

———suspend authority to increase drug copayment for treatment of non-service-connected disabilities and increase pension rates for certain surviving spouses (see H.R. 5082), H4424 [9JY]

Diseases: address the international HIV/AIDS pandemic (see S. 1936), S660 [12FE]

———combat cancer (see S. 1976), S1351 [28FE] (see H.R. 4596), H1673 [25AP]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (see S. 15), S11736 [20NO] (see S. 2525), S4387 [15MY] (see H.R. 5761), H9036 [19NO]

———improve data collection and dissemination between Federal and State registries to enhance the treatment and research of cancer (see S. 2955), S8753 [18SE]

———provide assistance to combat the HIV/AIDS pandemic in developing countries (see S. 2649), S5772 [19JN]

Economic Growth and Tax Relief Reconciliation Act: freeze and repeal portions of the tax reduction and apply savings to a comprehensive Medicare outpatient prescription drug benefit (see H.R. 3757), H366 [13FE]

Education: restrict the disqualification of students for drug offenses to those students who committed offenses while receiving student financial aid (see H.R. 3777), H523 [14FE]

Families and domestic relations: provide grants for mental health and substance abuse services for women and children who have been victims of domestic or sexual violence (see S. 2203), S2950 [18AP]

FDA: establish authority for the imposition of civil penalties for certain direct-to-consumer advertisements (see H.R. 4833), H3036 [23MY]

———grant authority to regulate tobacco (see S. 2626), S5584 [14JN]

———require labeling containing information applicable to pediatric patients (see S. 2394), S3505 [29AP] (see H.R. 4730), H2470 [14MY] (see H.R. 5594), H7738 [9OC]

Federal Food, Drug, and Cosmetic Act: amend relative to the development of products for rare diseases (see H.R. 4014), H1087 [20MR]

———ensure competition in pharmaceutical industry and increased access to affordable drugs (see S. 2818), S7469 [29JY]

———establish a program of fees relative to animal drugs (see S. 2665), S5851 [20JN] (see H.R. 4955), H3668 [18JN]

———provide greater access to affordable pharmaceuticals (see H.R. 5272), H5994 (see H.R. 5311), H5996 [26JY] (see H.R. 5350), H6129 [9SE]

———provide greater access to affordable pharmaceuticals (H.R. 1862), consideration (see H. Res. 517), H6085 [5SE]

Health: improve immunization rates by increasing the distribution of vaccines and improving and clarifying the vaccine injury compensation program (see S. 2053), S2260 [21MR] (see H.R. 5282), H5995 [26JY]

———improve patient safety and reduce incidence of medical errors (see S. 2590), S5041 [5JN] (see S. 3029), S9846 [2OC] (see H.R. 5478), H6776 [26SE]

———permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests (see S. 2207), S2950 [18AP]

———provide grants to health care providers to implement electronic prescription drug programs (see H.R. 4989), H3824 [21JN]

———voluntary reporting of medication error information to assist in developing and disseminating recommendations and information on preventing medication errors (see H.R. 4673), H2164 [7MY]

Health care professionals: establish an electronic system for practitioner monitoring of the dispensing of certain controlled substances (see S. 3033), S9846 [2OC] (see H.R. 5503), H6783 [30SE]

———improve training in prevention, recognition, and treatment of substance abuse and addiction (see S. 1966), S1208 [26FE]

Immigration: secure borders against terrorists, drug traffickers, and other illegal aliens, remove illegal and criminal aliens, reduce fraud, and reform the legal immigration system (see H.R. 5013), H3927 [25JN]

Insurance: coverage of prescription drugs (see H.R. 3913), H780 [7MR]

Law enforcement: establish a Community Oriented Policing Services anti-methamphetamine grant program (see S. 2030), S2076 [19MR]

———promote rural safety and improve rural law enforcement (see H.R. 5243), H5993 [26JY]

———provide grants for law enforcement training and equipment to combat methamphetamine labs (see H.R. 4027), H1087 [20MR]

Major League Baseball: implement a mandatory steroid testing program (see H. Res. 496), H5086 [22JY]

Medicaid: allow States to enter into drug rebate agreements to make prescription drugs available to individuals who are not otherwise eligible for medical assistance (see S. 2536), S4623 [21MY]

———require drug manufacturers to pay rebates to State drug discount programs to participate in Medicaid drug rebate agreements and increase rebate payments to State Medicaid programs (see S. 3142), S10676 [17OC]

Medicare: assure that enrollment in any prescription drug program is voluntary (see H.R. 5236), H5790 [25JY]

———coverage of certain self-administered intramuscular and subcutaneous drugs (see H.R. 5719), H8731 [13NO]

———coverage of chronic disease prescription drugs and disease management services (see H.R. 5219), H5790 [25JY]

———coverage of drugs and biologicals (see H.R. 5167), H4931 [18JY]

———coverage of outpatient prescription drugs (see S. 2625), S5584 [14JN] (see S. 2757), S7033 [18JY] (see H.R. 3626), H78 [24JA] (see H.R. 3684), H141 [5FE] (see H.R. 4751), H2607 [16MY] (see H.R. 4984), H3824 [21JN] (see H. Con. Res. 328), H366 [13FE]

———coverage of outpatient prescription drugs for low-income beneficiaries and provision of stop-loss protection for outpatient prescription drug expenses (see H.R. 4741), H2511 [15MY]

———ensure reimbursement for certain FDA-approved cancer drug therapies administered in hospital outpatient settings (see S. 2795), S7372 [25JY] (see H.R. 5218), H5789 [25JY]

———establish a prescription drug discount card endorsement program (see H.R. 4930), H3561 [13JN]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (see S. 2, 2729), S6808 [15JY] (see H.R. 4954), H3668 [18JN] (see H.R. 5019), H4068 [26JN]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (H.R. 4954), consideration (see H. Res. 465), H4068 [26JN]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (H.R. 4954), consideration (H. Res. 465), same-day consideration (see H. Res. 464), H4067 [26JN]

———establish voluntary outpatient prescription drug discount and security program (see S. 2736), S6867 [16JY]

———express importance of modernization, ensure solvency, and provide coverage options and prescription drug coverage (see S. Res. 269), S4330 [14MY]

———provide beneficiaries with access to prescription drugs at Federal Supply Schedule prices (see H.R. 5154), H4872 [17JY]

———reductions in prescription drug prices for beneficiaries and women with breast cancer (see S. 2747), S6947 [17JY]

———reform (see H.R. 5451), H6558 [24SE]

———require any reductions in payment rates for home respiratory medication nebulizer drugs to be offset by an equal increase in reimbursement for home respiratory medication professional services (see H.R. 4901), H3452 [11JN]

———require Dept. of HHS study on new technology payments under the prospective payment system for hospital outpatient department services (see S. 3041), S9901 [3OC]

———use estate tax revenue to finance an outpatient prescription drug program (see H.R. 4136), H1199 [10AP]

Medicare/Medicaid: conduct studies on comparative effectiveness and cost-effectiveness of prescription drugs that account for high levels of expenditures or use by individuals (see H.R. 4832), H3036 [23MY]

Medicine Equity and Drug Safety Act: implementation (see H. Res. 478), H4497 [10JY]

National Drug Control Strategy: support (see H. Res. 569), H6983 [2OC]

National Inhalants and Poison Prevention Awareness Week: designate (see S. Res. 206), S545 [8FE]

National Vaccine Injury Compensation Program: amend (see H.R. 3741), H365 [13FE]

NIH: biomedical research funding (see S. Res. 347), S10677 [17OC]

NIST: assist in development of reliable and valid tests for banned performance-enhancing substances and establish research program on long-term consequences of performance-enhancing substances (see H.R. 3683), H141 [5FE]

Pharmaceuticals: eligibility of certain applicants for approval of a generic drug for a competition-free period (see H.R. 4998), H3825 [21JN]

———grant waivers permitting individuals to import prescription drugs from Canada and amend laws relative to sale of prescription drugs through the Internet (see H.R. 5217), H5789 [25JY]

———importation of certain prescription drugs (see H.R. 5186), H5194 [23JY]

———permit commercial importation of prescription drugs from Canada (see S. 2244), S3303 [24AP] (see H.R. 4614), H1674 [25AP]

———require prescription drug manufacturers, packers, and distributors to disclose certain gifts provided in connection with promotional or marketing activities (see H.R. 5037), H4324 [27JN]

———require that pseudoephedrine be dispensed only upon a written prescription of a licensed practitioner (see H.R. 4690), H2354 [9MY]

Privacy: prohibit use of patient databases for marketing without the express consent of the patient (see S. 3064), S10040 [7OC]

Public Health Service Act: amend relative to pharmacy health professions programs (see H.R. 4992), H3824 [21JN]

———protection of human subjects in research (see H.R. 4697), H2355 [9MY]

Safety: promote safe and ethical clinical trials of drugs, and other test articles, on people overseas (see H.R. 5249), H5993 [26JY]

———provide protections for human participants in research (see S. 3060), S9983 [4OC]

Senior citizens: modify the eligibility criteria for supplemental foods provided under the Commodity Supplemental Food Program (see S. 2108), S2577 [11AP] (see H.R. 5107), H4553 [11JY]

States: permit requirement of parental consent relative to purchase of prescription drugs or devices for minors (see H.R. 4783), H2734 [21MY]

Tariff: bio-set injection RCC (see H.R. 4226), H1289 [15AP]

———D-mannose (see H.R. 4225), H1289 [15AP]

———ezetimibe (see S. 2093), S2577 [11AP] (see H.R. 4127), H1199 [10AP]

———HIV/AIDS drug (see S. 2172, 2173), S2828 [17AP]

———rhinovirus drug (see S. 2174), S2828 [17AP]

Taxation: apply excise tax to hepatitis A vaccines (see H.R. 4553), H1532 [23AP]

———limit manufacturers' deduction for advertising of FDA approved prescription drugs to the level of research and development expenditures (see S. 2486), S4064 [8MY] (see H.R. 4821), H2944 [22MY]

———treatment of direct-to-consumer advertisements of prescription drugs (see H.R. 5105), H4552 [11JY]

Terrorism: improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), consideration of conference report (see H. Res. 427), H2734 [21MY]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), corrections in enrollment (see S. Con. Res. 117), S4840 [23MY]

———provide incentives to commercial researchers to develop technologies and drugs to prevent and treat illnesses associated with a biological, chemical, or radiological weapons attack (see S. 3148), S10677 [17OC]

———use of illegal drug money to fund terrorist activities (see H. Con. Res. 323), H230 [8FE]

Tobacco products: eliminate quotas and price support, compensate quota holders and producers, establish Tobacco Quality Board, assess user fees, and grant FDA authority to regulate tobacco (see S. 2764), S7104 [19JY]

———eliminate quotas and price supports, compensate quota holders and producers, and establish a tobacco community reinvestment program (see S. 3004), S9229 [25SE] (see H.R. 5480), H6776 [26SE]

Women: ensure safe pregnancies by increasing research and data collection on treatments and cures for pregnancy complications and providing information to women, practitioners, and the public (see S. 2328), S3435 [25AP] (see H.R. 4602), H1673 [25AP]

———expand research for women in trauma (see S. 2559), S4839 [23MY]

———improve treatment for mental health and substance abuse needs of women with histories of trauma, including domestic and sexual violence (see S. 2204), S2950 [18AP]

Cloture motions

Federal Food, Drug, and Cosmetic Act: provide greater access to affordable pharmaceuticals (S. 812), S7299 [24JY], S7462 [29JY], S7633 [31JY]

———provide greater access to affordable pharmaceuticals (S. 812), motion to proceed, S6798 [15JY], S6883 [17JY]

Conference reports

Public Health Security and Bioterrorism Preparedness and Response Act (H.R. 3448), H2691-H2732 [21MY]

Cost Estimates

Medicare coverage of outpatient prescription drugs: CBO, S7024 [18JY], S7537 [30JY]

Declarations

$10 Billion for AIDS Treatment—2 Million People Worldwide in Treatment by 2004: International AIDS Conference, H4526 [11JY]

Descriptions

Public Health Security and Bioterrorism Preparedness and Response Act (H.R. 3448): Amendments Relative to Food Enforcement Authorities Provided Under the Federal Food, Drug, and Cosmetic Act, H2857 [22MY]

Excerpts

Legislation on the safety of the reimportation of prescription drugs, S6927 [17JY]

Factsheets

Nebraska Temporary/Permanent Judgeship Issue, H6749 [26SE]

Letters

Campus Classmate Offenders in Rehabilitation and Treatment (CORT) Act: Albert C. Yates, Colorado State University, S8676 [17SE]

———Karen Freeman Wilson, National Association of Drug Court Professionals, S8676 [17SE]

———Stuart A. VanMeveren, S8676 [17SE]

Certify safety and cost savings relative to commercial importation of prescription drugs from Canada: Donna E. Shalala, Dept. of HHS, S6910 [17JY]

———Lester M. Crawford, FDA, S6913 [17JY]

———Tommy G. Thompson, Sec. of HHS, S6910 [17JY]

Customs Service inspectors liabililty protections against racial profiling and illegal searches: Jason C. Erb, Council on American-Islamic Relations, H5982 [26JY]

———Laura Murphy, Rachel King, and Katie Corrigan, ACLU, H5981 [26JY]

———Representative Conyers, Committee on the Judiciary (House), H5982 [26JY]

———Wade Henderson, Leadership Conference on Civil Rights, H5981 [26JY]

Greater Access to Affordable Pharmaceuticals Act: Abbey S. Meyers, National Organization for Rare Disorders, Inc., S7641 [31JY]

———Carl B. Feldbaum, Biotechnology Industry Organization, S6994 [18JY], S7570 [30JY]

———Coalition for a Competitive Pharmaceutical Market, S6845 [16JY], S7641, S7648 [31JY]

———D. Michael Fisher, Attorney General of Pennsylvania, S7636 [31JY]

———Dick Wagoner, Jr., General Motors Corp., S7641 [31JY]

———Eliot Spitzer, Attorney General of New York, S7636 [31JY]

———James E. Rogan, Patent and Trademark Office, S7571 [30JY]

———Janell Mayo Duncan, Consumers Union, S7642 [31JY]

———Jody Hunter, Business for Affordable Medicine (organization), S6845 [16JY], S7648 [31JY]

———Kathleen D. Jaeger, Generic Pharmaceutical Association, S7641 [31JY]

———Michael K. Kirk, American Intellectual Property Law Association, S7346 [25JY]

———Senator Kennedy, S7026-S7028 [18JY]

———Stephen Mulloney, Massachusetts Biotechnology Council, S6995 [18JY]

Labeling and advertising requirements for dietary supplements containing ephedrine alkaloids and prohibit sales of such supplements to minors: Charles W. Fricke, and Kevin and Debra Riggins, S11675 [20NO]

Medicare coverage of outpatient prescription drugs: several health care organizations, S7545 [30JY]

———William D. Novelli, AARP, S10532 [16OC]

———William D. Novelli, Cecil Malone, and Maria Reynolds-Diaz, AARP, S7100 [19JY]

Medicare Modernization and Prescription Drug Act: William D. Novelli, AARP, H4288 [27JN]

Medicare Outpatient Prescription Drug Act: Barbara Kennelly, National Committee To Preserve Social Security and Medicare, S5586 [14JN], S7021 [18JY]

———Charles M. Loveless, American Federation of State, County and Municipal Employees, S5586 [14JN], S7021 [18JY]

———Edward F. Coyle, Alliance for Retired Americans, S5587 [14JN], S7021 [18JY]

———James Firman, National Council on the Aging, S5585 [14JN], S7020 [18JY]

———Kathleen Jaeger, Generic Pharmaceutical Association, S5587 [14JN], S7020 [18JY]

———Ronald F. Pollack, Families USA (organization), S5586 [14JN], S7021 [18JY]

———William D. Novelli, AARP, S5585 [14JN], S7020 [18JY]

———William Samuel, AFL-CIO, S5586 [14JN], S7021 [18JY]

Medicare voluntary outpatient prescription drug discount and security program: William D. Novelli, AARP, S7210, S7217 [23JY], S7283 [24JY]

Mother-to-child HIV/AIDS transmission prevention funding: Senator Helms, Committee on Foreign Relations (Senate), S5152 [6JN]

National Vaccine Injury Compensation Program: Elizabeth J. Noyes, Advisory Commission on Childhood Vaccines, S11178 [15NO]

———Louis Z. Cooper, American Academy of Pediatrics, S11179 [15NO]

Nomination of Keith D. Flink for Benevolent and Protective Order of Elks (fraternal organization) and DEA Enrique Camarena Award: Jeana Boyd, Justin Flink, and Jory Flink, S543 [8FE]

Prescription Drug User Fee Act authorization: Representatives Tauzin and Dingell, Committee on Energy and Commerce (House), H2856, H2859 [22MY]

Prescription Drug User Fee Act reauthorization: Tommy Thompson, Sec. of HHS, S5195 [6JN]

Preservation of Antibiotics for Human Treatment Act: Mohammad N. Akhter, American Public Health Association, S4283 [13MY]

Public misunderstanding about autism and vaccines: Neal Halsey, Johns Hopkins University, S11280 [18NO]

———Samuel L. Katz, Duke University, S11281 [18NO]

Senior Nutrition Act: Barb Packett, National Commodity Supplemental Food Program Association, S2582 [11AP]

———Frank Kubik, Focus—HOPE (organization), S2581 [11AP]

Lists

Berlin Township, NJ, School District Drug Abuse Resistance Education (D.A.R.E.) Program graduates, E725 [7MY]

FDA approval of buprenorphine for the treatment of heroin addiction press conference participants, S10658 [17OC]

Opponents and supporters of S. 812, Greater Access to Affordable Pharmaceuticals Act, S7638 [31JY]

Supporters of S. 2590, Patient Safety and Quality Improvement Act, S7368 [25JY]

Messages

Extradition Treaty With Lithuania: President Bush, S3904 [7MY]

Mutual Legal Assistance in Criminal Matters Treaty With Belize: President Bush, S6811 [15JY]

Mutual Legal Assistance in Criminal Matters Treaty With India: President Bush, S2373 [8AP]

Mutual Legal Assistance in Criminal Matters Treaty With Sweden: President Bush, S6810 [15JY]

National Drug Control Strategy: President Bush, S658 [12FE], H255 [12FE]

National Emergency Relative to Narcotics Traffickers in Colombia: President Bush, S3164 [23AP], S10568 [16OC], H1502 [23AP], H8013 [16OC]

Plan Colombia Funding Report: President Bush, S2410 [9AP], H1132 [9AP], H6529 [24SE]

Motions

Federal Food, Drug, and Cosmetic Act: provide greater access to affordable pharmaceuticals (S. 812), S7206 [23JY], S7283 [24JY], S7534 [30JY], S7633 [31JY]

Medicare: establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (H.R. 4954), H4297 [27JN]

Pharmaceuticals: consideration of legislation to provide greater access to affordable pharmaceuticals, H6957 [2OC]

Terrorism: improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), H638 [28FE]

Petitions and memorials

Colorado: national policy to provide health care and reform insurance procedures, E1108 [20JN]

Proposals

Consideration of legislation to provide greater access to affordable pharmaceuticals, H6856 [1OC], H6955 [2OC]

Questions and answers

Proposal to provide Medicare coverage of outpatient prescription drugs, S7624 [31JY]

Remarks in House

Afghanistan: prohibit assistance to entities involved in poppy cultivation or illicit drug trafficking and require reports on such activities, H2773, H2774 [21MY]

Animals: ensure use of certain antibiotic drugs in agriculture does not compromise human health by contributing to the development of antibiotic resistance (H.R. 3804), H2114 [7MY], E1147 [25JN]

Armed Forces: assignment of personnel to assist the INS and Customs Service with border control activities, H2365-H2368 [9MY]

Berlin Township, NJ: tribute to school district graduates from Drug Abuse Resistance Education (D.A.R.E.) Program, E725 [7MY]

Bolivia: drug interdiction efforts, E2138 [22NO]

Budget: allocation of funds, H788 [12MR]

Centers for Disease Control and Prevention: National Pharmaceutical Stockpile Program funding, H6998 [3OC]

Central Asia: provide assistance to prevent, treat, and control HIV/AIDS, tuberculosis, malaria, polio, and other infectious diseases that affect children (H.R. 5681), E1880 [17OC]

Coast Guard: Armed Drug Interdiction Mission funding, H8814 [14NO]

———drug interdiction helicopters lease extension, H5873 [26JY]

Colombia: counternarcotics and counterterrorism activities funding, H5225 [23JY], H5444 [24JY]

———limitation on the number of deployed U.S. military personnel, H2996-H3008 [23MY]

Committee on Appropriations (House): appropriations allocation revisions to H.R. 4954, Medicare Modernization and Prescription Drug Act, H4322 [27JN]

Congress: legislative priorities, H6391 [19SE]

Consumers: discrepancy in prescription drug prices between U.S. and foreign countries, H659 [5MR], H3207 [5JN], H3427 [11JN], H3495 [12JN], H3581 [17JN], H3645, H3646 [18JN], H3815, H3819 [21JN], H4485-H4491 [10JY], H5068 [22JY]

Coronado National Forest: environmental impact of drug trafficking and illegal immigration, H2156-H2162 [7MY], H3557-H3560 [13JN]

Courts: reduce disparity in penalties for crack and powder cocaine offenses and focus drug sentencing on seriousness of offense and culpability of offender, E2070 [15NO]

Crime: address the problem of pseudoephedrine smuggling into the U.S. from Canada (H. Con. Res. 317), E104 [6FE]

———foster local collaborations to ensure effective and efficient use of resources within the criminal and juvenile justice systems in dealing with mentally ill offenders (H.R. 5701), E1955 [24OC]

Customs Service: authorizing appropriations for personnel and technology to reduce delays at border crossings and strengthen drug enforcement (H.R. 2512), E204 [26FE]

Customs Service, Office of the U.S. Trade Representative, and ITC: authorizing appropriations (H.R. 3129), H2861-H2891 [22MY], E906 [24MY]

———authorizing appropriations (H.R. 3129), consideration (H. Res. 426), H2842-H2844 [22MY]

Dept. of HHS: authority to administer smallpox vaccine in the event of a smallpox attack or threat, E2041 [14NO]

———establish Office of Correctional Health (H.R. 2422), E232 [28FE]

Dept. of Homeland Security: appointment of a counternarcotics officer, H5656 [25JY]

Dept. of Justice: implement a program which provides for dedicated commuter lanes at land points of entry into the U.S. (H.R. 4837), E917 [24MY]

Dept. of Veterans Affairs: suspend authority to increase copayment for medication furnished on an outpatient basis for treatment of service-connected disabilities (H.R. 2820), H566, H611 [27FE], H770 [7MR]

Diseases: AIDS epidemic, H4503, H4525, H4526, H4527, H4531, H4533 [11JY], E110 [7FE], E124 [8FE], E1248 [12JY]

———combat cancer (H.R. 4596), E1878 [17OC]

———expand assistance to African Americans seriously affected by HIV/AIDS, E110 [7FE], E124 [8FE]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis, H4531 [11JY]

———improve access to HIV/AIDS-related treatments and services in sub-Saharan Africa and other developing countries, H5225 [23JY]

———research and development of new HIV/AIDS treatments, E1612 [19SE]

Drug abuse: national drug control policy, E1183 [28JN], E2075 [15NO]

Drugs: provide flexibility in descriptions of drug enforcement efforts of certain countries relative to foreign aid certification, H6651, H6654 [25SE]

Everett, Lynda S.: Texas Council of Community Mental Health Mental Retardation (MHMR) Centers, Inc., Betty Hardwick Best of Texas Award recipient, E1230 [10JY]

Federal Employees Health Benefits Program: coverage of contraceptives under any plan providing prescription drug coverage, H4915 [18JY]

Federal Food, Drug, and Cosmetic Act: amend relative to the development of products for rare diseases (H.R. 4014), H6814-H6818, H6883 [1OC]

———provide greater access to affordable pharmaceuticals (H.R. 1862), H2110 [7MY], H6268 [17SE], H6377, H6387, H6390, H6393, H6394, H6398 [19SE]

———provide greater access to affordable pharmaceuticals (H.R. 5272), H6261, H6268, H6297 [17SE]

Fighting Back Partnership of Vallejo, CA: Community Anti-Drug Coalitions of America Outstanding Coalition Award recipient, E110 [7FE]

Foreign aid: provide flexibility in descriptions of drug enforcement efforts of certain countries relative to foreign aid certification, H6651, H6654 [25SE]

Hall, Lucy: Robert Wood Johnson Foundation Community Health Leadership Award recipient, E1618 [19SE]

Health: national policy to provide health care and reform insurance procedures, E1108 [20JN]

———use of marijuana for medicinal purposes, E1545 [11SE]

———voluntary reporting of medication error information to assist in developing and disseminating recommendations and information on preventing medication errors (H.R. 4673), E726 [7MY]

House of Representatives: legislative priorities, H6475-H6478 [24SE]

Immigration: national policy, H2438-H2442 [14MY], H3155-H3157 [4JN], H3557-H3560 [13JN], H3593-H3596 [17JN]

———secure borders against terrorists, drug traffickers, and other illegal aliens, remove illegal and criminal aliens, reduce fraud, and reform the legal immigration system, H6154-H6159 [10SE], H6545-H6549 [24SE]

Immunex Corp.: tribute, H2933 [22MY]

International AIDS Conference: tribute, H4526, H4527, H4533 [11JY], E1257 [15JY]

Law enforcement: improve security at U.S. borders, H3557-H3560 [13JN], H3593-H3596 [17JN]

LVMH Group (business): marketing campaign for Parfums Christian Dior, E2039 [14NO]

Major League Baseball: implement a mandatory steroid testing program (H. Res. 496), H5048-H5050 [22JY], E1356 [25JY]

Medicaid: require States that provide prescription drug coverage to cover drugs that treat obesity (H.R. 1641), H268 [12FE]

Medicare: coverage of chronic disease prescription drugs and disease management services (H.R. 5219), E1386 [25JY]

———coverage of drugs and biologicals (H.R. 5167), E1302 [18JY]

———coverage of oral anticancer drugs (H.R. 1624), H2095 [2MY], E1878 [17OC]

———coverage of outpatient prescription drugs, H83, H85 [29JA], H1027, H1052, H1071, H1084 [20MR], H1690 [30AP], H2109, H2133, H2134, H2135, H2136 [7MY], H2169, H2170, H2227-H2233 [8MY], H2648-H2654 [20MY], H2664, H2665, H2815-H2820 [21MY], H2837, H2916, H2919 [22MY], H3076, H3143-H3150 [4JN], H3165, H3166, H3167, H3206 [5JN], H3299, H3300, H3301, H3397, H3398, H3399, H3437-H3442 [11JN], H3495, H3501-H3507 [12JN], H3548 [13JN], H3566, H3587-H3593 [17JN], H4342 [8JY], H4664-H4670 [15JY], H4678 [16JY], H4771 [17JY], H5093, H5094 [23JY], H6032-H6036 [4SE], H6078, H6079 [5SE], H6258, H6259, H6295-H6298 [17SE], H6352-H6357 [18SE], H8062 [12NO], E689 [3MY], E742 [8MY], E773 [10MY], E878 [22MY], E1014 [12JN], E1582 [17SE], E1611 [19SE]

———coverage of outpatient prescription drugs for women, H4075, H4150 [27JN]

———coverage of outpatient prescription drugs (H.R. 3626), H740 [7MR], H910 [14MR]

———coverage of outpatient prescription drugs (H.R. 3684), H4291 [27JN], E71 [5FE]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (H.R. 4954), H3605, H3610, H3613, H3641, H3652-H3659 [18JN], H3673, H3674, H3676, H3677, H3702, H3712-H3719 [19JN], H3725, H3726, H3727, H3728, H3750, H3753-H3760 [20JN], H3779, H3780, H3781, H3812 [21JN], H3827, H3828, H3841, H3842-H3849, H3852-H3854 [24JN], H3861, H3862, H3864, H3866, H3917-H3920 [25JN], H3932, H3933, H3934, H4030, H4031, H4032, H4039-H4045, H4051-H4056 [26JN], H4073, H4074, H4075, H4076, H4078, H4182-H4320 [27JN], H4330 [8JY], H4356 [9JY], H4578, H4664, H4665 [15JY], H4772 [17JY], H5093, H5094 [23JY], H5321 [24JY], H8027 [17OC], H8760 [14NO], E1107 [20JN], E1199, E1201, E1202, E1203 [8JY], E1220, E1223 [9JY], E1226 [10JY], E1913 [17OC]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (H.R. 4954), consideration (H. Res. 465), H4166-H4182 [27JN]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (H.R. 4954), consideration (H. Res. 465), same-day consideration (H. Res. 464), H6241 [12SE]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (H.R. 4954), motion to recommit, H4318, H4319 [27JN]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (H.R. 5019), H4029 [26JN], H4338-H4342 [8JY], E1161, E1163 [27JN]

———promote research for health promotion and disease prevention and add preventive benefits (H.R. 2058), H511 [14FE]

———reductions in prescription drug prices, H6295-H6298 [17SE]

———reductions in prescription drug prices (H.R. 1400), H2650, H2651 [20MY], H3145 [4JN]

———reform, H6696 [26SE]

———reform (H.R. 5451), E1643 [25SE]

Menesini, Kim: Drug Abuse Resistance Education (D.A.R.E.) Program Nevada Educator of the Year award recipient, H1007 [20MR]

Migon, Susan: New York Drug Abuse Resistance Education (D.A.R.E.) Educator of the Year award recipient, E968 [6JN]

Motor vehicles: prohibit operation with drugs or alcohol in the body of the driver at a land border port of entry (H.R. 2155), H7902-H7908 [15OC], E1881 [17OC], E2017 [14NO]

National Community Antidrug Coalition Institute: prohibit Federal involvement in management of grant funding, H5242 [23JY]

National Drug Control Strategy: support (H. Res. 569), H7038-H7041 [7OC], E1808 [9OC]

National security: completion of fencing project between San Diego, CA, and Tijuana, Mexico, H5696, H5697 [25JY]

National Vaccine Injury Compensation Program: amend (H.R. 3741), H9093 [22NO], E154 [14FE]

Nebraska: authorize permanent circuit court judgeship, H6749, H6750 [26SE]

NIST: assist in development of reliable and valid tests for banned performance-enhancing substances and establish research program on long-term consequences of performance-enhancing substances (H.R. 3683), H220 [7FE]

Office of National Drug Control Policy: prohibit use of national media campaign funding for payments to Ogilvy and Mather Corp., H5337-H5341 [24JY], E1490 [4SE]

Parents' Resource Institute for Drug Education: tribute to World Drug Prevention Conference, E521 [12AP]

Pharmaceuticals: consideration of legislation to provide greater access to affordable pharmaceuticals, H6955-H6958 [2OC]

———effect of advertising on prescription drug prices, H659 [5MR]

———impact of gifts and benefits provided to physicians by prescription drug manufacturers on the efficacy and cost-effectiveness of prescription drugs, E1801 [9OC]

———pediatric vaccine manufacturer liability protection, H9089-H9093 [22NO], E2143 [22NO]

———provide access and choice for use of generic drugs under State Medicaid programs, H539 [26FE]

Rosenbaum, James M.: assessment of testimony on drug sentencing guidelines before the Committee on the Judiciary (House), E2070 [15NO]

Solberg, Mary Ann: Leadership Troy (organization) Distinguished Citizen award recipient, E1837 [11OC]

Terrorism: improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), H638 [28FE]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), conference report, H2803 [21MY], H2844-H2860 [22MY], E915, E916, E919-E921, E930 [24MY]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), consideration of conference report (H. Res. 427), H2838-H2842 [22MY]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), corrections in enrollment (S. Con. Res. 117), H3101 [4JN]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), motion to instruct conferees, H638-H641 [28FE]

Ukrop, James: Virginia Pharmacists Association Research and Education Foundation Rx for Excellence Award recipient, E478 [10AP]

Remarks in Senate

Animals: ensure use of certain antibiotic drugs in agriculture does not compromise human health by contributing to the development of antibiotic resistance (S. 2508), S4283, S4284 [13MY]

Antitrust policy: enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs, S7565-S7571 [30JY], S7645 [31JY]

———enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs (S. 2677), S6019 [25JN]

———enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs (S. 754), S7460 [29JY], S11339-S11342 [18NO]

Barthwell, Andrea G.: nomination to be Deputy Director for Demand Reduction at the Office of National Drug Control Policy, S151 [25JA]

Children and youth: amend certain laws relative to pediatric studies of drugs, S5192 [6JN]

———meet mental health and substance abuse treatment needs of incarcerated children and youth (S. 1965), S1210 [26FE]

Coast Guard: drug interdiction helicopters lease extension, S7803 [1AU]

Colleges and universities: provide grants to States to establish partnerships among colleges and universities and surrounding communities to reduce underage and binge drinking and illicit drug use by students (S. 3167), S11083 [14NO]

Colombia: support democratically elected Government and efforts to combat narcotics trafficking and counter threats from terrorist organizations, S3525-S3527 [30AP], S5894 [21JN]

———support democratically elected Government and efforts to counter threats from terrorist organizations, S5162 [6JN]

———U.S. policy, S6860 [16JY]

Congress: legislative priorities, S8336 [9SE], S8629-S8631 [17SE]

Consumers: correct impediments to allowing importation of prescription drugs into the U.S. by pharmacists and wholesalers for resale, S2637-S2639 [15AP]

Contraceptives: require equitable coverage of drugs, devices, and services under health insurance plans, S7535 [30JY]

Coos Bay, OR: tribute to Millicoma Middle School eighth graders for anti-drug efforts, S4834 [23MY]

Courts: authorize grants for establishment of quasi-judicial campus drug courts at colleges and universities (S. 2941), S8675 [17SE]

Crime: foster local collaborations to ensure effective and efficient use of resources within the criminal and juvenile justice systems in dealing with mentally ill offenders (S. 3147), S10711-S10716 [17OC]

———prohibit opening, maintaining, managing, controlling, renting, leasing, making available for use, or profiting from any place for the purpose of manufacturing, distributing, or using any controlled substance (S. 2633), S5705, S5706 [18JN], S10218 [9OC]

———respond to the illegal production, distribution, and use of methamphetamines (S. 2763), S7107-S7109 [19JY]

Delancey Street Foundation: anniversary, S2258 [21MR]

Democratic Party: national agenda, S4555 [20MY]

Dept. of Defense: establish the Clara Barton Center for Domestic Preparedness as a Government-owned contractor-operated biological weapon vaccine production facility, S6199 [27JN]

Dept. of HHS: certify safety and cost savings relative to commercial importation of prescription drugs from Canada, S6910-S6922, S6925-S6930 [17JY]

Dept. of Justice: status of tobacco industry lawsuit relative to health risks and marketing and manufacturing practices, S1925 [14MR]

Dept. of Veterans Affairs: tribute to Medical Research Service for research into oral treatment for smallpox, S2406 [9AP]

Diseases: address the international HIV/AIDS pandemic, S7424 [26JY]

———address the international HIV/AIDS pandemic (S. 1936), S664 [12FE]

———AIDS epidemic, S1853 [13MR], S2241-S2243 [21MR]

———combat cancer (S. 1976), S1361-S1365 [28FE], S4615 [21MY]

———establish national smallpox vaccination policy, S9096 [24SE]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis, S2241-S2243 [21MR], S5147-S5162, S5195 [6JN], S11543-S11546 [19NO]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (S. 2525), S4402-S4404 [15MY], S5779 [19JN]

———improve access to HIV/AIDS-related treatments and services in sub-Saharan Africa and other developing countries, S2241-S2243 [21MR]

———improve access to HIV/AIDS-related treatments and services in sub-Saharan Africa and other developing countries (H.R. 2069), S6679 [11JY], S6700-S6702 [12JY], S11693 [20NO]

———improve access to HIV/AIDS-related treatments and services in the Caribbean nations, S3489 [29AP]

———improve data collection and dissemination between Federal and State registries to enhance the treatment and research of cancer (S. 2955), S8757, S8758 [18SE]

———provide assistance to combat the HIV/AIDS pandemic in developing countries (S. 2649), S5779 [19JN], S5890 [21JN]

Drug abuse: combat trafficking, distribution, and abuse of ``Ecstasy'' and other club drugs, S9699 [1OC]

———reduce illegal drug use and trafficking and help provide appropriate drug education, prevention and treatment programs (S. 304), S9889 [3OC], S10035 [7OC]

FDA: approval of buprenorphine for the treatment of heroin addiction, S10655-S10658 [17OC]

———funding, S5171 [6JN], S5284 [10JN]

———grant authority to regulate tobacco (S. 2626), S5598-S5601 [14JN]

———require labeling containing information applicable to pediatric patients (S. 2394), S7861 [1AU]

Federal aid programs: review Federal programs on substance abuse, prevention, treatment, education, and research, S10035 [7OC]

Federal Food, Drug, and Cosmetic Act: amend relative to the development of products for rare diseases (H.R. 4014), S10769 [17OC]

———establish a program of fees relative to animal drugs (S. 2665), S5862-S5866 [20JN]

———provide greater access to affordable pharmaceuticals (S. 812), S6802, S6811 [15JY], S6873 [16JY], S6883-S6931 [17JY], S6968-S6972, S6976-S7016, S7019-S7028 [18JY], S7093-S7100 [19JY], S7127, S7134-S7158 [22JY], S7180-S7189, S7194, S7218 [23JY], S7244-S7246, S7249-S7263, S7282-S7299 [24JY], S7327-S7336, S7340, S7342-S7350, S7366 [25JY], S7398-S7413, S7423, S7424 [26JY], S7457, S7460, S7464 [29JY], S7505, S7514-S7551, S7565-S7571, S7614-S7616 [30JY], S7618-S7651 [31JY], S7849-S7851, S7853-S7858, S7875-S7878 [1AU], S8630, S8631 [17SE], S9182 [25SE], S10407 [15OC]

———provide greater access to affordable pharmaceuticals (S. 812), motion to proceed, S6797-S6801 [15JY], S6818-S6829, S6831-S6858 [16JY], S6878-S6883 [17JY]

———provide greater access to affordable pharmaceuticals (S. 812), unanimous-consent agreement, S7545 [30JY]

Flink, Keith D.: Benevolent and Protective Order of Elks (fraternal organization) and DEA Enrique Camarena Award recipient, S543 [8FE]

FTC: study on pharmaceutical industry marketing rules, S7460 [29JY]

Government regulations: establish labeling and advertising requirements for dietary supplements containing ephedrine alkaloids and prohibit sales of such supplements to minors, S11672-S11675 [20NO]

Health: improve immunization rates by increasing the distribution of vaccines and improving and clarifying the vaccine injury compensation program (S. 2053), S2276-S2278 [21MR], S5922 [24JN]

———improve patient safety and reduce incidence of medical errors (S. 2590), S5052, S5053 [5JN], S7367 [25JY]

———improve patient safety and reduce incidence of medical errors (S. 3029), S9848 [2OC]

———permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests (S. 2207), S2965 [18AP]

Health care professionals: improve training in prevention, recognition, and treatment of substance abuse and addiction (S. 1966), S1210 [26FE]

International AIDS Conference: tribute, S6815 [16JY]

Law enforcement: establish a Community Oriented Policing Services anti-methamphetamine grant program (S. 2030), S2078 [19MR]

McClellan, Mark B.: nomination to be FDA Commissioner, S10639 [17OC]

Medicaid: allow States to enter into drug rebate agreements to make prescription drugs available to individuals who are not otherwise eligible for medical assistance (S. 2536), S4626 [21MY]

Medicare: coverage of outpatient prescription drugs, S2383 [9AP], S2909 [18AP], S3550-S3552 [30AP], S3589-S3591, S3606, S3607 [1MY], S3793-S3795 [2MY], S4087, S4088 [9MY], S4192 [10MY], S4293 [14MY], S4345 [15MY], S4513 [17MY], S4742-S4744, S4824, S4833 [23MY], S4933 [4JN], S5024 [5JN], S5341 [11JN], S5465-S5468 [13JN], S6802, S6811 [15JY], S6814, S6816-S6818 [16JY], S6887, S6890-S6892, S6894, S6922-S6926 [17JY], S6969-S6971, S6976-S6992, S7019-S7026 [18JY], S7095-S7100 [19JY], S7134-S7158 [22JY], S7180-S7189, S7194-S7207, S7216 [23JY], S7244-S7246 [24JY], S7327, S7359, S7366 [25JY], S7423, S7424 [26JY], S7446, S7464 [29JY], S7505, S7514, S7535-S7551, S7565, S7614-S7616 [30JY], S7618-S7633, S7642, S7646, S7647, S7649-S7651 [31JY], S7840, S7849-S7851, S7853-S7858 [1AU], S10408, S10410 [15OC], S10532-S10546 [16OC], S10637, S10655 [17OC]

———coverage of outpatient prescription drugs (S. 10), S4618 [21MY]

———coverage of outpatient prescription drugs (S. 2625), S5585-S5597 [14JN], S5663 [18JN], S5792-S5794 [20JN], S6180-S6182 [27JN], S6600-S6603 [11JY]

———coverage of outpatient prescription drugs (S. 2757), S7041 [18JY]

———ensure reimbursement for certain FDA-approved cancer drug therapies administered in hospital outpatient settings (S. 2795), S7374 [25JY]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure, S6856-S6858 [16JY], S7001-S7005, S7022-S7026 [18JY], S7093-S7100 [19JY], S7134-S7146, S7157 [22JY], S7180-S7189, S7194-S7207, S7210 [23JY], S7464 [29JY], S7514-S7516, S7543-S7547 [30JY], S7621, S7626, S7627 [31JY]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (H.R. 4954), S5823 [20JN], S6594 [10JY], S6729 [15JY]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (S. 2), S6811 [15JY], S6873 [16JY]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (S. 2), unanimous-consent request, S10536 [16OC]

———establish voluntary outpatient prescription drug coverage program and modernize and reform payments and the regulatory structure (S. 2729), S6873-S6875 [16JY]

———establish voluntary outpatient prescription drug discount and security program, S6753 [15JY], S6924-S6926 [17JY], S7207-S7218 [23JY], S7249-S7263, S7282, S7283 [24JY]

———express importance of modernization, ensure solvency, and provide coverage options and prescription drug coverage (S. Res. 269), S4334 [14MY]

———provide adequate coverage of immunosuppressive drugs for certain transplant patients, S7366 [25JY]

———require Dept. of HHS study on new technology payments under the prospective payment system for hospital outpatient department services (S. 3041), S9907 [3OC]

Merck & Co., Inc.: anniversary of MECTIZAN Donation Program, S8558 [12SE]

National Guard: tribute to Counter Drug States Plan Program, S7880 [1AU]

National Inhalants and Poison Prevention Awareness Week: designate (S. Res. 206), S556 [8FE], S1982 [15MR]

Native Americans: authorize the integration and consolidation of alcohol and substance abuse programs and services provided by tribal governments (S. 210), S8696 [17SE]

NIH: biomedical research funding (S. Res. 347), S10730-S10732 [17OC]

Older Americans Act: funding, S4833 [23MY]

Oregon: tribute to South Coast Interagency Narcotics Team, S4834 [23MY]

Pharmaceutical industry: research and development costs, S4273 [13MY]

Pharmaceuticals: bioequivalence standards for generic drugs, S6993-S6996 [18JY]

———condemn industry advertising campaign relative to generic drugs, S9182 [25SE]

———pediatric vaccine manufacturer liability protection, S11022, S11025 [14NO], S11164, S11168, S11169, S11175-S11181 [15NO], S11279-S11281, S11286 [18NO], S11360, S11364-S11370 [19NO]

———permit commercial importation of prescription drugs from Canada, S4087 [9MY], S6894-S6922, S6925-S6930 [17JY]

———permit commercial importation of prescription drugs from Canada (S. 2244), S3316-S3319 [24AP], S3502 [29AP], S3550-S3552 [30AP], S3793-S3795 [2MY], S5341 [11JN]

———require companies to disclose any gifts or incentives given to doctors or health care providers and require manufacturers to disclose any rebates given to pharmaceutical benefits managers, S7007 [18JY]

Prescription Drug User Fee Act: reauthorization, S5195 [6JN]

Privacy: prohibit use of patient databases for marketing without the express consent of the patient (S. 3064), S10046 [7OC]

Public Health Service Act: amend relative to pharmacy health professions programs (S. 1806), S9927-S9930 [3OC]

Red Ribbon Week: support goals (H. Con. Res. 84), S11339 [18NO]

Republican Party: national agenda, S3257 [24AP]

Safety: provide protections for human participants in research (S. 3060), S9993 [4OC]

Senate: legislative priorities, S8967 [20SE], S9003 [23SE]

Senior citizens: modify the eligibility criteria for supplemental foods provided under the Commodity Supplemental Food Program (S. 2108), S2580-S2582 [11AP]

Silbert, Mimi: Jewish National Fund (organization) Woman of Valor Award recipient, S7739 [31JY]

South America: impact of free trade on drug interdiction efforts, S7819 [1AU]

States: clarify authority to enter into drug rebate agreements with manufacturers in order to provide prescription drug coverage to individuals not covered by Medicaid, S6978-S6982, S7010-S7016 [18JY]

Taxation: limit manufacturers' deduction for advertising of FDA approved prescription drugs to the level of research and development expenditures (S. 2486), S4077 [8MY], S4087 [9MY], S4824 [23MY]

Terrorism: commend efforts of news media to provide citizens with the necessary information to prepare and protect against bioterrorism, S5282 [10JN]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), conference report, S4772-S4786 [23MY], S5195 [6JN], S5282 [10JN]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), conference report—unanimous-consent agreement, S4761 [23MY]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), conference report—unanimous-consent request, S4760 [23MY]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), corrections in enrollment (S. Con. Res. 117), S4787 [23MY]

———provide incentives to commercial researchers to develop technologies and drugs to prevent and treat illnesses associated with a biological, chemical, or radiological weapons attack (S. 3148), S10716-S10728 [17OC]

Treaties and agreements: removal of injunction of secrecy, S2373 [8AP], S3904 [7MY]

Women: ensure safe pregnancies by increasing research and data collection on treatments and cures for pregnancy complications and providing information to women, practitioners, and the public (S. 2328), S3440 [25AP]

Reports

Autism—A Novel Form of Mercury Poisoning: Sallie Bernard, Albert Enayati, Lyn Redwood, Heidi Roger, and Teresa Binstock, H9096-H9107 [22NO]

Prescription Drug User Fee Act Reauthorization Performance Goals and Procedures, S5195-S5200 [6JN]

What Do We Know From the Peer-Reviewed Scientific Literature About Thimerosal?, H9093-H9095 [22NO]

Reports filed

Consideration of Conference Report on H.R. 3448, Public Health Security and Bioterrorism Preparedness and Response Act: Committee on Rules (House) (H. Res. 427) (H. Rept. 107-483), H2734 [21MY]

Consideration of H.R. 3129, Customs Border Security Act: Committee on Rules (House) (H. Res. 426) (H. Rept. 107-482), H2734 [21MY]

Consideration of H.R. 4954, Medicare Modernization and Prescription Drug Act: Committee on Rules (House) (H. Res. 465) (H. Rept. 107-553), H4068 [26JN]

Drug Competition Act: Committee on the Judiciary (Senate) (S. 754) (S. Rept. 107-167), S5850 [20JN]

Greater Access to Affordable Pharmaceuticals Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 812), S6649 [11JY]

Health Care Providers Grants To Implement Electronic Prescription Drug Programs: Committee on Energy and Commerce (House) (H.R. 4989) (H. Rept. 107-545), H4064, H4067 [26JN]

International AIDS Treatment and Prevention Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 2649), S6361 [8JY]

Labeling Requirement Containing Information Applicable to Pediatric Patients: Committee on Health, Education, Labor, and Pensions (Senate) (S. 2394) (S. Rept. 107-300), S10114 [8OC]

Medicare Coverage of Outpatient Prescription Drugs: Committee on Energy and Commerce (House) (H.R. 4984) (H. Rept. 107-551), H4064, H4067 [26JN]

Medicare Modernization and Prescription Drug Act: Committee on Ways and Means (House) (H.R. 4954) (H. Rept. 107-539), H4064, H4067 [26JN]

National Inhalants and Poison Prevention Awareness Week: Committee on the Judiciary (Senate) (S. Res. 206), S1935 [14MR]

Native American Alcohol and Substance Abuse Program Consolidation Act: Committee on Indian Affairs (Senate) (S. 210) (S. Rept. 107-250), S8091 [3SE]

Pharmacy Education Aid Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 1806), S9595 [30SE]

Prohibit Motor Vehicle Operation With Drugs or Alcohol in the Body of the Driver at a Land Border Port of Entry: Committee on the Judiciary (House) (H.R. 2155) (H. Rept. 107-754), H7929 [15OC]

Public Health Security and Bioterrorism Preparedness and Response Act: Committee of Conference (H.R. 3448) (H. Rept. 107-481), H2734 [21MY]

Public Health Service Act Amendment Relative to Pharmacy Health Professions Programs: Committee on Energy and Commerce (House) (H.R. 4992) (H. Rept. 107-548), H4064, H4067 [26JN]

Rare Diseases Orphan Product Development Act: Committee on Energy and Commerce (House) (H.R. 4014) (H. Rept. 107-702), H6925 [1OC]

Reducing Americans' Vulnerability to Ecstasy (RAVE) Act: Committee on the Judiciary (Senate) (S. 2633), S6249 [27JN]

Require Labeling Containing Information Applicable to Pediatric Patients: Committee on Health, Education, Labor, and Pensions (Senate) (S. 2394), S7898 [1AU]

Requirements Relative to the Sale of, or the Offer To Sell, Prescription Drugs Through the Internet: Committee on Energy and Commerce (House) (H.R. 4990) (H. Rept. 107-546), H4064, H4067 [26JN]

Safe Motherhood Act for Research and Treatment (SMART Mom Act): Committee on Health, Education, Labor, and Pensions (Senate) (S. 2328), S8671 [17SE]

Same-Day Consideration of H. Res. 465, Consideration of H.R. 4954, Medicare Modernization and Prescription Drug Act: Committee on Rules (House) (H. Res. 464) (H. Rept. 107-552), H4067 [26JN]

U.S. Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act: Committee on Foreign Relations (Senate) (S. 2525) (S. Rept. 107-206), S6361 [8JY]

Rulings of the Chair

Pharmaceuticals: consideration of legislation to provide greater access to affordable pharmaceuticals, H6957 [2OC]

Statements

FDA Approval of Buprenorphine for the Treatment of Heroin Addiction: Charles R. Schuster, Wayne State University, S10657 [17OC]

———Chris-Ellyn Johanson, Wayne State University, S10657 [17OC]

———Herbert Kleber, Columbia University, S10658 [17OC]

———James H. Woods, University of Michigan, S10657 [17OC]

Greater Access to Affordable Pharmaceuticals Act: David Beier, S7346 [25JY]

———Eliot Spitzer, Attorney General of New York, S7637 [31JY]

No Help for Retirees With Employer or Union Coverage From Graham, S7624 [31JY]

Random Drug Testing of Students: Lindy Stetson, H3141 [4JN]

Summaries

Biological, Chemical and Radiological Weapons Countermeasures Research Act (S. 3148), S10724 [17OC]

Global Access to HIV/AIDS Prevention, Awareness, Education, and Treatment Act (H.R. 2069), S6701 [12JY]

Tables

AIDS Program funding level, S5156 [6JN]

Cost to States of proposal to provide Medicare coverage of outpatient prescription drugs, S7623 [31JY]

Coverage gap in proposal to provide Medicare coverage of outpatient prescription drugs, S7623 [31JY]

Schedule required to achieve goals of Tripling of Biomedical Research Resolution, S10732 [17OC]

Vaccine mercury burden and autism risk in the U.S., H9108 [22NO]

Testimonies

Autism Epidemic: Lee Grossman, Autism Society of America, H9095 [22NO]

Texts of

H. Res. 426, consideration of H.R. 3129, Customs Border Security Act, H2842 [22MY]

H. Res. 427, consideration of conference report on H.R. 3448, Public Health Security and Bioterrorism Preparedness and Response Act, H2838 [22MY]

H. Res. 465, consideration of H.R. 4954, Medicare Modernization and Prescription Drug Act, H4166 [27JN]

H. Res. 496, implement a mandatory steroid testing program for Major League Baseball, H5048 [22JY]

H. Res. 569, support National Drug Control Strategy, H7038 [7OC]

H.R. 2155, prohibit motor vehicle operation with drugs or alcohol in the body of the driver at a land border port of entry, H7902 [15OC]

H.R. 3129, Customs Border Security Act, H2869-H2878 [22MY]

H.R. 4014, Rare Diseases Orphan Product Development Act, H6815 [1OC]

H.R. 4954, Medicare Modernization and Prescription Drug Act, H4182, H4226-H4269 [27JN]

S. 210, Native American Alcohol and Substance Abuse Program Consolidation Act, S8696-S8699 [17SE]

S. 812, Greater Access to Affordable Pharmaceuticals Act, S6884-S6887 [17JY], S8007-S8012 [1AU]

S. 1806, Pharmacy Education Aid Act, S9927-S9930 [3OC]

S. 1966, Health Professionals Substance Abuse Education Act, S1211 [26FE]

S. 2030, COPS Anti-Methamphetamine Act, S2078 [19MR]

S. 2053, Improved Vaccine Affordability and Availability Act, S2278-S2281 [21MR]

S. 2108, Senior Nutrition Act, S2581 [11AP]

S. 2244, Prescription Drug Price Parity for Americans Act, S3316-S3318 [24AP]

S. 2486, Fair Advertising and Increased Research (FAIR) Act, S4077 [8MY]

S. 2536, Rx Flexibility for States Act, S4627 [21MY]

S. 2625, Medicare Outpatient Prescription Drug Act, S5587-S5597 [14JN]

S. 2626, Youth Smoking Prevention and Public Health Protection Act, S5601-S5613 [14JN]

S. 2665, Animal Drug User Fee Act, S5863-S5865 [20JN]

S. 2677, Consumer Access to Prescription Drugs Improvement Act, S6020-S6025 [25JN]

S. 2764, Tobacco Livelihood and Economic Assistance for Our Farmers Act, S7109-S7126 [19JY]

S. 2941, Campus Classmate Offenders in Rehabilitation and Treatment (CORT) Act, S8675 [17SE]

S. 3064, Health Records Confidentiality Act, S10047 [7OC]

S. 3147, Mentally Ill Offender Treatment and Crime Reduction Act, S10712-S10714 [17OC]

S. Con. Res. 117, corrections in enrollment of H.R. 3448, Public Health Security and Bioterrorism Preparedness and Response Act, S4787, S4876 [23MY], H3101 [4JN]

S. Res. 206, National Inhalants and Poison Prevention Awareness Week, S556 [8FE], S1982 [15MR]

S. Res. 269, express importance of Medicare modernization, ensure solvency, and provide coverage options and prescription drug coverage, S4334 [14MY]

S. Res. 347, Tripling of Biomedical Research Resolution, S10730 [17OC]